# Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy

> **NCT07668700** · PHASE2 · COMPLETED · sponsor: **Hameed Latif Hospital, Lahore** · enrollment: 300 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting (PONV)
- Gynecological Laparoscopic Surgery
- Anesthesia Complications

## Interventions

- **DRUG:** Midazolam 0.05 mg/kg IV as adjunct to dexamethasone and ondansetron for PONV prevention

## Key facts

- **NCT ID:** NCT07668700
- **Lead sponsor:** Hameed Latif Hospital, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-02
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668700, "Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*